Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
2.290
-0.010 (-0.43%)
At close: Jul 24, 2026, 4:00 PM EDT
2.281
-0.009 (-0.41%)
After-hours: Jul 24, 2026, 7:48 PM EDT
Lexicon Pharmaceuticals Employees
Lexicon Pharmaceuticals had 81 employees as of December 31, 2025. The number of employees decreased by 22 or -21.36% compared to the previous year.
Employees
81
Change (1Y)
-22
Growth (1Y)
-21.36%
Revenue / Employee
$859,790
Profits / Employee
-$322,086
Market Cap
1.02B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 81 | -22 | -21.36% |
| Dec 31, 2024 | 103 | -182 | -63.86% |
| Dec 31, 2023 | 285 | 150 | 111.11% |
| Dec 31, 2022 | 135 | 48 | 55.17% |
| Dec 31, 2021 | 87 | 9 | 11.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MeiraGTx Holdings | 409 |
| EyePoint | 214 |
| Sana Biotechnology | 142 |
| Olema Pharmaceuticals | 137 |
| Cullinan Therapeutics | 109 |
| Inventiva | 77 |
| Vor Biopharma | 76 |
| Alto Neuroscience | 68 |
LXRX News
- 7 weeks ago - Lexicon Pharmaceuticals Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Lexicon to Present Data at the American Diabetes Association (ADA) 2026 Scientific Sessions - GlobeNewsWire
- 2 months ago - Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Lexicon Pharmaceuticals Slides: Investor presentation - Filings
- 2 months ago - Lexicon Pharmaceuticals Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 2 months ago - Lexicon Pharmaceuticals to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference - GlobeNewsWire
- 2 months ago - Lexicon price target raised to $3.10 from $2.30 at Citi - TheFly
- 2 months ago - Lexicon Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts